<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02679222</url>
  </required_header>
  <id_info>
    <org_study_id>2016-541</org_study_id>
    <nct_id>NCT02679222</nct_id>
  </id_info>
  <brief_title>Comparing the Ketogenic Effect of Coconut Oil and Different MCTs</brief_title>
  <acronym>MCT-Coco</acronym>
  <official_title>Comparing the Ketogenic Effect of Coconut Oil and Different Medium-chain Triglycerides</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Université de Sherbrooke</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Université de Sherbrooke</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to compare the ketogenic effect of coconut oil and three MCT oils
      (60-40 , tricaprylin and triheptanoate) on the production of ketones in healthy adults. Each
      oil are evaluated individually or in combination over a 8h-period during which repeated blood
      sampling is performed.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study is composed of eight successive visits. Each visit consists of the consumption of
      one individual oil or a mixture of oils (20 g of coconut oil or 10 g of coconut oil + 10 g of
      MCT 60-40 or 20 g MCT 60-40 or 10 g coconut oil + 10 g tricaprylin or 20 g tricaprylin or 10
      g coconut oil + 10 g triheptanoate or 20 g triheptanoate) and a 8h follow-up during which
      repeated blood samples are taken for laboratory analysis (plasma beta-hydroxybutyrate,
      acetoacetate, glucose, free fatty acids, triglycerides, total cholesterol, lactate and
      insulin).
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 2015</start_date>
  <completion_date type="Actual">March 1, 2017</completion_date>
  <primary_completion_date type="Actual">December 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Plasma Ketone Concentrations</measure>
    <time_frame>8 hours</time_frame>
    <description>Total ketones = Plasma acetoacetate (µmol/L) + beta-hydroxybutyrate (µmol/L) measured over a 8 hour period (i.e. daily mean).
Samples are taken every 30 minutes on a 8 hours period. The mean is reported here.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Plasma Acetoacetate/Beta-hydroxybutyrate Ratio</measure>
    <time_frame>8 hours</time_frame>
    <description>Plasma ratio of acetoacetate (µmol/L)/ beta-hydroxybutyrate (µmol/L) measured over a 8 hour period (i.e area-under-the-curve over 8 hours).</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">10</enrollment>
  <condition>Healthy Adults</condition>
  <arm_group>
    <arm_group_label>Supplementation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Protocol involved seven separate but identical metabolic study days for each participant. the test substances were evaluated in random order: vehicle (Control) or 20 mL of the test oils (Coconut oil; tricaprin; tricaprylin; MCT [tricaprylin/tricaprin]; coconut oil + MCT [50:50]; Coconut oil + tricaprylin [50:50]) taken twice, once at breakfast and once at mid-day.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Coconut oil</intervention_name>
    <description>20 g of coconut oil</description>
    <arm_group_label>Supplementation</arm_group_label>
    <other_name>Coco</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Coconut oil + MCT</intervention_name>
    <description>10 g of coconut oil + 10 g of MCT (60 of C8 + 40 of C10)</description>
    <arm_group_label>Supplementation</arm_group_label>
    <other_name>Coco+MCT</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>MCT</intervention_name>
    <description>20 g of MCT (60 of C8+40 of C10)</description>
    <arm_group_label>Supplementation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Coconut oil + tricaprylin</intervention_name>
    <description>10 g coconut oil + 10 g tricaprylin</description>
    <arm_group_label>Supplementation</arm_group_label>
    <other_name>Coco+C8</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Tricaprylin</intervention_name>
    <description>20 g tricaprylin</description>
    <arm_group_label>Supplementation</arm_group_label>
    <other_name>C8</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Tricaprin</intervention_name>
    <description>20 g tricaprin</description>
    <arm_group_label>Supplementation</arm_group_label>
    <other_name>C10</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Control</intervention_name>
    <description>No supplement taken on this visit</description>
    <arm_group_label>Supplementation</arm_group_label>
    <other_name>CTL</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy adult over 18 y old.

        Exclusion Criteria:

          -  Fasting plasma glucose ≥7.0 mM (diabetics or pre-diabetics);

          -  Smoking

          -  Clinically-significant gastro-intestinal disease/conditions.

          -  Clinically-significant liver disease/dysfunction.

          -  Clinically-significant cardiac disease/conditions.

          -  Clinically-significant abnormal coagulation.

          -  Taking a medication that could affect lipid and glucose metabolism

          -  Hypertension

          -  Pregnancy or breastfeeding

          -  Exercising more than 3 times a week
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Stephen Cunnane, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CSSS-IUGS - CIUSSS de L'Estrie - CHUS - Université de Sherbrooke</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Research Centre on Aging (CSSS-IUGS - CIUSSS de l'Estrie - CHUS)</name>
      <address>
        <city>Sherbrooke</city>
        <state>Quebec</state>
        <zip>J1H4C4</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>February 1, 2016</study_first_submitted>
  <study_first_submitted_qc>February 5, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 10, 2016</study_first_posted>
  <results_first_submitted>February 11, 2019</results_first_submitted>
  <results_first_submitted_qc>March 23, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">April 6, 2020</results_first_posted>
  <last_update_submitted>March 23, 2020</last_update_submitted>
  <last_update_submitted_qc>March 23, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 6, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Ketones</keyword>
  <keyword>Coconut oil</keyword>
  <keyword>Medium Chain Triglycerides</keyword>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Supplementation</title>
          <description>Protocol involved seven separate but identical metabolic study days for each participant. the test substances were evaluated in random order: vehicle (Control) or 20 mL of the test oils (Coconut oil; tricaprin; tricaprylin; MCT [tricaprylin/tricaprin]; coconut oil + MCT [50:50]; Coconut oil + tricaprylin [50:50]) taken twice, once at breakfast and once at mid-day.
Coconut oil: 20 g of coconut oil
Coconut oil + MCT: 10 g of coconut oil + 10 g of MCT (60 of C8 + 40 of C10)
MCT: 20 g of MCT (60 of C8+40 of C10)
Coconut oil + tricaprylin: 10 g coconut oil + 10 g tricaprylin
Tricaprylin: 20 g tricaprylin
Tricaprin: 20 g tricaprin
Control: No supplement taken on this visit</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="10"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="9"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>No time for project</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Supplementation</title>
          <description>Protocol involved seven separate but identical metabolic study days for each participant. the test substances were evaluated in random order: vehicle (Control) or 20 mL of the test oils (Coconut oil; tricaprin; tricaprylin; MCT [tricaprylin/tricaprin]; coconut oil + MCT [50:50]; Coconut oil + tricaprylin [50:50]) taken twice, once at breakfast and once at mid-day.
Coconut oil: 20 g of coconut oil
Coconut oil + MCT: 10 g of coconut oil + 10 g of MCT (60 of C8 + 40 of C10)
MCT: 20 g of MCT (60 of C8+40 of C10)
Coconut oil + tricaprylin: 10 g coconut oil + 10 g tricaprylin
Tricaprylin: 20 g tricaprylin
Tricaprin: 20 g tricaprin
Control: No supplement taken on this visit</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="9"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="9"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="34" spread="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="9"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Canada</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="9"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Body mass index</title>
          <units>kg/m^2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="9"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="24" spread="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Glucose</title>
          <units>mmol/L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="9"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4.3" spread="0.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ketones</title>
          <units>µmol/L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="9"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="90" spread="61"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Plasma Ketone Concentrations</title>
        <description>Total ketones = Plasma acetoacetate (µmol/L) + beta-hydroxybutyrate (µmol/L) measured over a 8 hour period (i.e. daily mean).
Samples are taken every 30 minutes on a 8 hours period. The mean is reported here.</description>
        <time_frame>8 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Control</title>
            <description>vehicle (Control) taken twice, once at breakfast and once at mid-day.
Control: No supplement taken on this visit</description>
          </group>
          <group group_id="O2">
            <title>Medium Chain Triglyceride</title>
            <description>20 mL of MCT taken twice, once at breakfast and once at mid-day.
MCT: 20 g of MCT (60 of C8+40 of C10)</description>
          </group>
          <group group_id="O3">
            <title>Tricaprin</title>
            <description>20 mL of MCT tricaprin taken twice, once at breakfast and once at mid-day.
Tricaprin: 20 g tricaprin</description>
          </group>
          <group group_id="O4">
            <title>Tricaprylin</title>
            <description>20 mL of tricaprylin taken twice, once at breakfast and once at mid-day.
Tricaprylin: 20 g tricaprylin</description>
          </group>
          <group group_id="O5">
            <title>Coconut Oil</title>
            <description>20 mL of Coconut oil taken twice, once at breakfast and once at mid-day.
Coconut oil: 20 g of coconut oil</description>
          </group>
          <group group_id="O6">
            <title>Coconut Oil + MCT</title>
            <description>20 mL of coconut oil + MCT taken twice, once at breakfast and once at mid-day.
Coconut oil + MCT: 10 g of coconut oil + 10 g of MCT (60 of C8 + 40 of C10)</description>
          </group>
          <group group_id="O7">
            <title>Coconut Oil + Tricaprylin</title>
            <description>20 mL of Coconut oil + tricaprylin [50:50]) taken twice, once at breakfast and once at mid-day.
Coconut oil + tricaprylin: 10 g coconut oil + 10 g tricaprylin</description>
          </group>
        </group_list>
        <measure>
          <title>Plasma Ketone Concentrations</title>
          <description>Total ketones = Plasma acetoacetate (µmol/L) + beta-hydroxybutyrate (µmol/L) measured over a 8 hour period (i.e. daily mean).
Samples are taken every 30 minutes on a 8 hours period. The mean is reported here.</description>
          <units>µmol/L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="9"/>
                <count group_id="O2" value="9"/>
                <count group_id="O3" value="9"/>
                <count group_id="O4" value="9"/>
                <count group_id="O5" value="9"/>
                <count group_id="O6" value="9"/>
                <count group_id="O7" value="9"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="69" spread="92"/>
                    <measurement group_id="O2" value="294" spread="85"/>
                    <measurement group_id="O3" value="109" spread="41"/>
                    <measurement group_id="O4" value="363" spread="109"/>
                    <measurement group_id="O5" value="107" spread="97"/>
                    <measurement group_id="O6" value="141" spread="39"/>
                    <measurement group_id="O7" value="235" spread="79"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Plasma Acetoacetate/Beta-hydroxybutyrate Ratio</title>
        <description>Plasma ratio of acetoacetate (µmol/L)/ beta-hydroxybutyrate (µmol/L) measured over a 8 hour period (i.e area-under-the-curve over 8 hours).</description>
        <time_frame>8 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Control</title>
            <description>vehicle (Control) taken twice, once at breakfast and once at mid-day.
Control: No supplement taken on this visit</description>
          </group>
          <group group_id="O2">
            <title>Medium Chain Triglyceride</title>
            <description>20 mL of MCT taken twice, once at breakfast and once at mid-day.
MCT: 20 g of MCT (60 of C8+40 of C10)</description>
          </group>
          <group group_id="O3">
            <title>Tricaprin</title>
            <description>20 mL of MCT tricaprintaken twice, once at breakfast and once at mid-day.
Tricaprin: 20 g tricaprin</description>
          </group>
          <group group_id="O4">
            <title>Tricaprylin</title>
            <description>20 mL of tricaprylin taken twice, once at breakfast and once at mid-day.
Tricaprylin: 20 g tricaprylin</description>
          </group>
          <group group_id="O5">
            <title>Coconut Oil</title>
            <description>20 mL of Coconut oil taken twice, once at breakfast and once at mid-day.
Coconut oil: 20 g of coconut oil</description>
          </group>
          <group group_id="O6">
            <title>Coconut Oil + MCT</title>
            <description>20 mL of coconut oil + MCT taken twice, once at breakfast and once at mid-day.
Coconut oil + MCT: 10 g of coconut oil + 10 g of MCT (60 of C8 + 40 of C10)</description>
          </group>
          <group group_id="O7">
            <title>Coconut Oil +t Tricaprylin</title>
            <description>20 mL of Coconut oil + tricaprylin [50:50]) taken twice, once at breakfast and once at mid-day.
Coconut oil + tricaprylin: 10 g coconut oil + 10 g tricaprylin</description>
          </group>
        </group_list>
        <measure>
          <title>Plasma Acetoacetate/Beta-hydroxybutyrate Ratio</title>
          <description>Plasma ratio of acetoacetate (µmol/L)/ beta-hydroxybutyrate (µmol/L) measured over a 8 hour period (i.e area-under-the-curve over 8 hours).</description>
          <units>Ratio</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="9"/>
                <count group_id="O2" value="9"/>
                <count group_id="O3" value="9"/>
                <count group_id="O4" value="9"/>
                <count group_id="O5" value="9"/>
                <count group_id="O6" value="9"/>
                <count group_id="O7" value="9"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.7" spread="3.2"/>
                    <measurement group_id="O2" value="6.9" spread="1.5"/>
                    <measurement group_id="O3" value="7.7" spread="1.1"/>
                    <measurement group_id="O4" value="5.9" spread="1.0"/>
                    <measurement group_id="O5" value="9.5" spread="2.9"/>
                    <measurement group_id="O6" value="8.4" spread="1.3"/>
                    <measurement group_id="O7" value="8.1" spread="2.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>7 visits of 8 hours</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Supplementation</title>
          <description>Protocol involved seven separate but identical metabolic study days for each participant. the test substances were evaluated in random order: vehicle (Control) or 20 mL of the test oils (Coconut oil; tricaprin; tricaprylin; MCT [tricaprylin/tricaprin]; coconut oil + MCT [50:50]; Coconut oil + tricaprylin [50:50]) taken twice, once at breakfast and once at mid-day.
Coconut oil: 20 g of coconut oil
Coconut oil + MCT: 10 g of coconut oil + 10 g of MCT (60 of C8 + 40 of C10)
MCT: 20 g of MCT (60 of C8+40 of C10)
Coconut oil + tricaprylin: 10 g coconut oil + 10 g tricaprylin
Tricaprylin: 20 g tricaprylin
Tricaprin: 20 g tricaprin
Control: No supplement taken on this visit</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="9"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="9"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Pr. Stephen Cunnane</name_or_title>
      <organization>Université de Sherbrooke</organization>
      <phone>819-780-2220 ext 45670</phone>
      <email>stephen.cunnane@usherbrooke.ca</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

